Safety Study of CTS21166 to Treat Alzheimer Disease
NCT00621010
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
CTS21166 (ZPQ-21166)
Sponsor
CoMentis